|An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis|
MPR Berry, CM Graham, FW McNab, Z Xu, SAA Bloch, T Oni, ...
Nature 466 (7309), 973-977, 2010
|Slum health: arresting COVID-19 and improving well-being in urban informal settlements|
J Corburn, D Vlahov, B Mberu, L Riley, WT Caiaffa, SF Rashid, A Ko, ...
Journal of urban health 97 (3), 348-357, 2020
|Randomized placebo-controlled trial of prednisone for paradoxical TB-associated immune reconstitution inflammatory syndrome|
G Meintjes, RJ Wilkinson, C Morroni, DJ Pepper, K Rebe, MX Rangaka, ...
AIDS (London, England) 24 (15), 2381, 2010
|Detection of tuberculosis in HIV-infected and-uninfected African adults using whole blood RNA expression signatures: a case-control study|
M Kaforou, VJ Wright, T Oni, N French, ST Anderson, N Bangani, ...
PLoS medicine 10 (10), e1001538, 2013
|Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa|
AR Martineau, S Nhamoyebonde, T Oni, MX Rangaka, S Marais, ...
Proceedings of the National Academy of Sciences 108 (47), 19013-19017, 2011
|Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series|
DJ Pepper, S Marais, G Maartens, K Rebe, C Morroni, MX Rangaka, T Oni, ...
Clinical Infectious Diseases 48 (11), e96-e107, 2009
|Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa|
R Wood, H Liang, H Wu, K Middelkoop, T Oni, MX Rangaka, RJ Wilkinson, ...
The international journal of tuberculosis and lung disease 14 (4), 406-412, 2010
|Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy|
CI Bloom, CM Graham, MPR Berry, KA Wilkinson, T Oni, F Rozakeas, ...
Public Library of Science 7 (10), e46191, 2012
|Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa-a cross sectional study|
T Oni, E Youngblood, A Boulle, N McGrath, RJ Wilkinson, NS Levitt
BMC infectious diseases 15 (1), 1-8, 2015
|Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F] fluoro-D-glucose positron emission and computed tomography|
H Esmail, RP Lai, M Lesosky, KA Wilkinson, CM Graham, AK Coussens, ...
Nature medicine 22 (10), 1090-1093, 2016
|Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases|
NF Walker, SO Clark, T Oni, N Andreu, L Tezera, S Singh, L Saraiva, ...
American journal of respiratory and critical care medicine 185 (9), 989-997, 2012
|Chronic diseases and multi-morbidity-a conceptual modification to the WHO ICCC model for countries in health transition|
T Oni, N McGrath, R BeLue, P Roderick, S Colagiuri, CR May, NS Levitt
BMC public health 14 (1), 1-7, 2014
|Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial|
BP Ndiaye, F Thienemann, M Ota, BS Landry, M Camara, S Dièye, ...
The Lancet Respiratory Medicine 3 (3), 190-200, 2015
|Understanding the rise of cardiometabolic diseases in low-and middle-income countries|
JJ Miranda, T Barrientos-Gutierrez, C Corvalan, AA Hyder, M Lazo-Porras, ...
Nature medicine 25 (11), 1667-1679, 2019
|Programmed death ligand 1 is over‐expressed by neutrophils in the blood of patients with active tuberculosis|
FW McNab, MPR Berry, CM Graham, SAA Bloch, T Oni, KA Wilkinson, ...
European journal of immunology 41 (7), 1941-1947, 2011
|High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening|
T Oni, R Burke, R Tsekela, N Bangani, R Seldon, HP Gideon, K Wood, ...
Thorax 66 (8), 669-673, 2011
|Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of …|
T Oni, N Unwin
International health 7 (6), 390-399, 2015
|Peer reviewed: culture matters in communicating the global response to COVID-19|
CO Airhihenbuwa, J Iwelunmor, D Munodawafa, CL Ford, T Oni, ...
Preventing chronic disease 17, 2020
|Cities and health: an evolving global conversation|
M Grant, C Brown, WT Caiaffa, A Capon, J Corburn, C Coutts, CJ Crespo, ...
Cities & health 1 (1), 1-9, 2017
|A cross-sectional and spatial analysis of the prevalence of multimorbidity and its association with socioeconomic disadvantage in South Africa: a comparison between 2008 and 2012|
A Weimann, D Dai, T Oni
Social Science & Medicine 163, 144-156, 2016